0001415889-21-004264.txt : 20210907 0001415889-21-004264.hdr.sgml : 20210907 20210907171633 ACCESSION NUMBER: 0001415889-21-004264 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210902 FILED AS OF DATE: 20210907 DATE AS OF CHANGE: 20210907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rayner Craig R. CENTRAL INDEX KEY: 0001834170 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39799 FILM NUMBER: 211240028 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER, SUITE 101 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Certara, Inc. CENTRAL INDEX KEY: 0001827090 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER, SUITE 101 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 716-7900 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER, SUITE 101 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 form4-09072021_020948.xml X0306 4 2021-09-02 0001827090 Certara, Inc. CERT 0001834170 Rayner Craig R. C/O CERTARA, INC. 100 OVERLOOK CENTER, SUITE 101 PRINCETON NJ 08540 false true false false PRESIDENT, INTEGRATED DRUG DEV Common Stock 2021-09-02 4 S 0 3900 33.51 D 366572 D Common Stock 2021-09-02 4 S 0 1900 34.15 D 364672 D Common Stock 2021-09-02 4 S 0 48462 36.64 D 316210 D Common Stock 2021-09-02 4 S 0 200 37.21 D 316010 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $32.91 to $33.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $34.12 to $34.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $36.19 to $37.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $37.21 to $37.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Richard M. Traynor, Attorney-in Fact for Craig R. Raynor 2021-09-07